Ken Griffin Edwards Lifesciences Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 390,200 shares of EW stock, worth $29.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
390,200
Previous 1,072,900
63.63%
Holding current value
$29.6 Million
Previous $79.4 Million
64.39%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding EW
# of Institutions
1,376Shares Held
486MCall Options Held
2.77MPut Options Held
2.05M-
Vanguard Group Inc Valley Forge, PA69.2MShares$5.25 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.87 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$2.21 Billion0.42% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.96 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.67 Billion0.12% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...